Search

Search Constraints

You searched for: Author/Creator Sallan, Stephen E.

Search Results

1. A thymidylate synthase polymorphism is associated with increased risk for bone toxicity among children treated for acute lymphoblastic leukemia. Issue 7 (13th December 2016)

2. An investigation of toxicities and survival in Hispanic children and adolescents with ALL: Results from the Dana‐Farber Cancer Institute ALL Consortium protocol 05‐001. Issue 3 (1st November 2017)

3. Corrigendum. Issue 3 (31st December 2020)

4. Development and pilot evaluation of a new nanoparticle-capture workflow for doxorubicin-induced toxicity biomarker identification. Issue 2 (November 2015)

5. Efficacy and Toxicity of Pegaspargase and Calaspargase Pegol in Childhood Acute Lymphoblastic Leukemia: Results of DFCI 11-001. Issue 31 (1st November 2021)

6. Fluctuations in dietary intake during treatment for childhood leukemia: A report from the DALLT cohort. Issue 6 (December 2019)

7. Functional and structural differences in the hippocampus associated with memory deficits in adult survivors of acute lymphoblastic leukemia12. Issue 2 (8th August 2012)

8. Genomic and clinical characterization of B/T mixed phenotype acute leukemia reveals recurrent features and T‐ALL like mutations. Issue 11 (26th September 2018)

9. Identification of prognostic factors in childhood T‐cell acute lymphoblastic leukemia: Results from DFCI ALL Consortium Protocols 05‐001 and 11‐001. Issue 1 (7th October 2020)

10. Identification of prognostic factors in childhood T‐cell acute lymphoblastic leukemia: Results from DFCI ALL Consortium Protocols 05‐001 and 11‐001. Issue 1 (7th October 2020)